Skyknight Capital
SkyKnight Capital describes an investment approach focused on market-leading businesses in acyclical growth sectors alongside management teams. Its published criteria include $25 – 250M+ equity investments, 25 – 75%+ equity ownership, 6 – 10+ year partnerships, and target company EBITDA of $5+ Million.
What stands out about Skyknight Capital
SkyKnight Capital publicly focuses on healthcare, financial services, and tech-enabled services businesses in North America. It describes an engaged ownership model and publishes criteria of $25 – 250M+ equity investments, 25 – 75%+ equity ownership, 6 – 10+ year partnerships, and $5+ Million EBITDA.[1][2][3][4][5][6]
What does Skyknight Capital invest in?
SkyKnight Capital is a private equity firm focused on investing in market-leading businesses in acyclical growth sectors alongside exceptional management teams.
The firm lists offices in Burlingame, California, and New York, New York. SEC/IAPD lists SKYKNIGHT CAPITAL, L.P. as an investment adviser with CRD #281570 and SEC file number 801-110953, with SEC registration effective August 1, 2017.[1][2][11]
SkyKnight’s published investment criteria include $25 – 250M+ equity investments, 25 – 75%+ equity ownership, and 6 – 10+ year partnerships.
The firm describes an engaged value-creation model covering leadership and governance, M&A and capital allocation, strategy and operations, and digital transformation.[3][4]
Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.
Published criteria: SkyKnight's public criteria include $25 – 250M+ equity investments, 25 – 75%+ equity ownership, 6 – 10+ year partnerships, and target company EBITDA of $5+ Million. A July 2026 announcement stated that the firm manages ~$6.5 billion in assets, has 35 dedicated professionals, and closed Fund V with $2 billion in commitments.[4][5]
What should a business owner evaluate before considering a transaction with Skyknight Capital?
An owner evaluating SkyKnight can compare the proposed transaction with the firm’s published criteria: $25 – 250M+ equity investments, 25 – 75%+ equity ownership, 6 – 10+ year partnerships, and target company EBITDA of $5+ Million. The firm’s public materials also describe management alignment and support across leadership and governance, M&A and capital allocation, strategy and operations, and digital transformation.
Because the official investments page does not disclose transaction value, purchase price, financing terms, ownership percentage, or consideration terms for listed investments, those points should be established for the specific proposal. The What We Seek page also does not state a required seller rollover percentage or fee schedule.[3][4][6]
What portion of the seller's equity, if any, would be expected to roll over
How would SkyKnight apply its 6 – 10+ year partnership criterion to the proposed investment, and what exit or liquidity options would be contemplated
What companies does Skyknight Capital target?
SkyKnight states that it seeks businesses that are or can be built into market leaders, with attractive unit economics and EBITDA of $5+ Million.
Its public criteria page states equity-investment, ownership, partnership-duration, sector, EBITDA, and return criteria, but does not state a universal minimum enterprise value, revenue threshold, fee schedule, or required seller rollover percentage.[4]
SkyKnight identifies healthcare, financial services, and tech-enabled services as its investment industries.[4]
SkyKnight’s July 2026 fund announcement states that it has made investments in healthcare, financial services, and tech-enabled services companies in North America. The firm’s contact page lists offices in Burlingame, California, and New York, New York.[2][5]
The sources cited for this profile establish SkyKnight’s investment in businesses and its value-creation activities, including M&A and capital allocation. They do not establish a separate public platform-versus-add-on acquisition framework.[3][4]
SkyKnight’s official investments page lists current and former portfolio companies, along with each company’s sector, location, and year partnered. Listed companies include AdaptHealth, Amwins, Ampirical, Balavant, Core Specialty, DOCS Dermatology, FirstCall Mechanical, Force Electrical, GoodVets, MacKay, Pearl Street, Simplicity, Wasteology Group, and WhiteWater Express.[6]
SkyKnight entered into a definitive agreement to partner with Apex Infusion on July 24, 2026; Apex’s clinician-led management team was described as retaining a significant ownership stake and continuing to lead the business.
Wasteology Group received a growth investment from SkyKnight in November 2025, with its founder remaining a significant shareholder and the existing management team continuing to lead the company. Force Electrical Services received a growth investment in October 2025, with its founder remaining a significant shareholder and the existing management team continuing to lead the company.
SkyKnight’s official news archive also identifies a September 17, 2025 announcement for Tangram’s spinout from Heffernan and launch of the SkyKnight-backed Balavant Insurance Group MGA platform.[7][8][9][10]
What is not clear from Skyknight Capital's public investment criteria?
The official investments page lists portfolio companies, status, sector, location, and partnership year, but does not disclose transaction value, purchase price, financing terms, ownership percentage, or consideration terms for the listed investments.
The official What We Seek page does not state a universal minimum enterprise value, revenue threshold, fee schedule, or required seller rollover percentage.[4][6]
Questions to ask when evaluating Skyknight Capital as a buyer or investment partner
What ownership percentage and governance rights would SkyKnight seek for the proposed transaction?
What portion of the seller's equity, if any, would be expected to roll over?
How would SkyKnight apply its 6 – 10+ year partnership criterion to the proposed investment, and what exit or liquidity options would be contemplated?
What valuation, leverage, financing, management incentive, indemnity, and earnout terms would apply?
Which value-creation resources would be assigned, and how would decision-making be divided between SkyKnight and management?
Sources & research notes
- Official website / firm overview
- Official website / firm overview
- Services / capabilities
- Investment strategy
- Geography / market coverage
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- SEC investment adviser record
- SEC filing / regulatory record
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.
